BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
CYP51
,
calcium channel activity
,
Breast Cancer
,
Kidney
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
signal transduction inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
Molecular characterization of novel PPARalpha agonists
Aortic valve interstitial cells treated with gamma-secretase/Notch signaling inhibitor
Naive T (CD4+ CD45RA+) and memory T (CD4+ CD45RO+) cells treated with TMP778
Human colorectal cancer cells treated with inhibitors of PI3Kinase - AKT signaling pathway
Dental pulp cells treated with JAG1 and gamma secretase inhibitor DAPT
Explore Curated Studies Results
Literature
Most Relevant Literature
HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunothera…
Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Childr…
JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a c…
Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors.
A serine protease inhibitor induces type 1 regulatory T cells through IFN-γ/STAT1 signaling.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Trip…
Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC
Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-…
Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcino…
Combination of JAK2 Inhibitor and Erythropoiesis-stimulating Agent in Myelofibrosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ